Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 194

1.

Comparative genomics and functional analysis of a highly adhesive dairy Lactobacillus paracasei subsp. paracasei IBB3423 strain.

Koryszewska-Bagińska A, Gawor J, Nowak A, Grynberg M, Aleksandrzak-Piekarczyk T.

Appl Microbiol Biotechnol. 2019 Jul 29. doi: 10.1007/s00253-019-10010-1. [Epub ahead of print]

PMID:
31359102
2.

[Dual trigger with gonadotropin-releasing hormone agonist and hCG to improve oocyte maturation rate].

Herbemont C, El Kouhen I, Brax A, Vinolas C, Dagher-Hayeck B, Comtet M, Calvo J, Sarandi S, Grynberg M, Cédrin-Durnerin I, Sifer C.

Gynecol Obstet Fertil Senol. 2019 Jul - Aug;47(7-8):568-573. doi: 10.1016/j.gofs.2019.06.012. Epub 2019 Jul 2. French.

PMID:
31271894
3.

Anti-Müllerian Hormone in Fertility Preservation: Clinical and Therapeutic Applications.

Sonigo C, Beau I, Binart N, Grynberg M.

Clin Med Insights Reprod Health. 2019 Jun 14;13:1179558119854755. doi: 10.1177/1179558119854755. eCollection 2019. Review.

4.

French-style genetics v. 2.0: The "e-CohortE" project.

Stoeklé HC, Bollet M, Cobat A, Charlier P, Bloch OC, Flatot J, Draghi C, Tolyan V, Hervé C, Desvaux P, Uzan L, Grynberg M, Alcaïs A, Tolédano A, Vogt G.

Clin Genet. 2019 Jun 29. doi: 10.1111/cge.13595. [Epub ahead of print]

PMID:
31254389
5.

Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumours: guidelines from the French national network dedicated to rare gynaecological cancers.

Rousset-Jablonski C, Selle F, Adda-Herzog E, Planchamp F, Selleret L, Pomel C, Daraï E, Chabbert-Buffet N, Pautier P, Trémollières F, Guyon F, Rouzier R, Laurence V, Chopin N, Faure-Conter C, Bentivegna E, Vacher-Lavenu MC, Lhomme C, Floquet A, Treilleux I, Lecuru F, Gouy S, Kalbacher E, Genestie C, Thibault MR, Ferron G, Devouassoux M, Kurtz JE, Provansal M, Namer M, Joly F, Pujade-Lauraine E, Grynberg M, Querleu D, Morice P, Gompel A, Ray-Coquard I.

Eur J Cancer. 2019 Jul;116:35-44. doi: 10.1016/j.ejca.2019.04.018. Epub 2019 Jun 3.

PMID:
31170563
6.

Understanding Follicular Output Rate (FORT) and its Implications for POSEIDON Criteria.

Grynberg M, Labrosse J.

Front Endocrinol (Lausanne). 2019 Apr 16;10:246. doi: 10.3389/fendo.2019.00246. eCollection 2019.

7.

A comparison of the effects of three luteal phase support protocols with estrogen on in vitro fertilization-embryo transfer outcomes in patients on a GnRH antagonist protocol.

Scheffer JB, Scheffer BB, Carvalho RF, Aguiar AP, Lozano DHM, Labrosse J, Grynberg M.

JBRA Assist Reprod. 2019 Mar 15. doi: 10.5935/1518-0557.20190012. [Epub ahead of print]

8.

Disentangling the complexity of low complexity proteins.

Mier P, Paladin L, Tamana S, Petrosian S, Hajdu-Soltész B, Urbanek A, Gruca A, Plewczynski D, Grynberg M, Bernadó P, Gáspári Z, Ouzounis CA, Promponas VJ, Kajava AV, Hancock JM, Tosatto SCE, Dosztanyi Z, Andrade-Navarro MA.

Brief Bioinform. 2019 Jan 30. doi: 10.1093/bib/bbz007. [Epub ahead of print]

PMID:
30698641
9.

Serum progesterone concentration and live birth rate in frozen-thawed embryo transfers with hormonally prepared endometrium.

Cédrin-Durnerin I, Isnard T, Mahdjoub S, Sonigo C, Seroka A, Comtet M, Herbemont C, Sifer C, Grynberg M.

Reprod Biomed Online. 2019 Mar;38(3):472-480. doi: 10.1016/j.rbmo.2018.11.026. Epub 2019 Jan 5.

PMID:
30642638
10.

BRCA1/2 gene mutations do not affect the capacity of oocytes from breast cancer candidates for fertility preservation to mature in vitro.

Grynberg M, Dagher Hayeck B, Papanikolaou EG, Sifer C, Sermondade N, Sonigo C.

Hum Reprod. 2019 Feb 1;34(2):374-379. doi: 10.1093/humrep/dey358.

PMID:
30561604
11.

Serum antimüllerian hormone is associated with the number of oocytes matured in vitro and with primordial follicle density in candidates for fertility preservation.

Sermondade N, Sonigo C, Sifer C, Valtat S, Ziol M, Eustache F, Grynberg M.

Fertil Steril. 2019 Feb;111(2):357-362. doi: 10.1016/j.fertnstert.2018.10.018. Epub 2018 Dec 7.

PMID:
30527837
12.

Comparison of GnRH agonist and hCG for priming in vitro maturation cycles in cancer patients undergoing urgent fertility preservation.

El Hachem H, Sonigo C, Benard J, Presse M, Sifer C, Sermondade N, Grynberg M.

PLoS One. 2018 Dec 6;13(12):e0208576. doi: 10.1371/journal.pone.0208576. eCollection 2018.

13.

Impact of post-warming culture duration on clinical outcomes of vitrified good-quality blastocyst transfers: a prospective randomized study.

Herbemont C, Chekroune S, Bonan S, Cedrin-Durnerin I, Vivot A, Sonigo C, Boujenah J, Grynberg M, Sifer C.

Fertil Steril. 2018 Dec;110(7):1290-1297. doi: 10.1016/j.fertnstert.2018.07.1153.

PMID:
30503128
14.

A cost-effectiveness analysis comparing the originator follitropin alfa to its biosimilars in patients undergoing a medically assisted reproduction program from a French perspective.

Grynberg M, Murphy C, Doré C, Fresneau L, Paillet S, Petrica N, Frédérique M, Ravonimbola H.

J Med Econ. 2018 Nov 21:1-15. doi: 10.1080/13696998.2018.1551226. [Epub ahead of print]

PMID:
30461330
15.

Anti Müllerian Hormone: More than a biomarker of female reproductive function.

Victoria M, Labrosse J, Krief F, Cédrin-Durnerin I, Comtet M, Grynberg M.

J Gynecol Obstet Hum Reprod. 2019 Jan;48(1):19-24. doi: 10.1016/j.jogoh.2018.10.015. Epub 2018 Oct 22. Review.

PMID:
30352309
16.

Global pentapeptide statistics are far away from expected distributions.

Poznański J, Topiński J, Muszewska A, Dębski KJ, Hoffman-Sommer M, Pawłowski K, Grynberg M.

Sci Rep. 2018 Oct 11;8(1):15178. doi: 10.1038/s41598-018-33433-8.

17.

COMFFETI, Combined Fresh and Frozen Embryo Transfers per Individual: A New Index of Quality Control for The Performance of emberyologic Labs in The Emerging Era of Segmentation of Cycle and Freeze-All Strategy.

Papanikolaou EG, Timotheou E, Tatsi P, Janssens H, Grynberg M, Athanasiadis A, Zafeirati C, Najdecki R, Petousis S.

Int J Fertil Steril. 2019 Jan;12(4):339-342. doi: 10.22074/ijfs.2019.5424. Epub 2018 Oct 2.

18.

Individualized Prediction of Menses Recovery After Chemotherapy for Early-stage Breast Cancer: A Nomogram Developed From UNICANCER PACS04 and PACS05 Trials.

Pistilli B, Mazouni C, Zingarello A, Faron M, Saghatchian M, Grynberg M, Spielmann M, Kerbrat P, Roché H, Lorgis V, Bachelot T, Campone M, Levy C, Gonçalves A, Lesur A, Veyret C, Vanlemmens L, Lemonnier J, Delaloge S.

Clin Breast Cancer. 2019 Feb;19(1):63-70. doi: 10.1016/j.clbc.2018.08.005. Epub 2018 Aug 23.

PMID:
30241966
19.

High-throughput ovarian follicle counting by an innovative deep learning approach.

Sonigo C, Jankowski S, Yoo O, Trassard O, Bousquet N, Grynberg M, Beau I, Binart N.

Sci Rep. 2018 Sep 10;8(1):13499. doi: 10.1038/s41598-018-31883-8.

20.

AMH prevents primordial ovarian follicle loss and fertility alteration in cyclophosphamide-treated mice.

Sonigo C, Beau I, Grynberg M, Binart N.

FASEB J. 2019 Jan;33(1):1278-1287. doi: 10.1096/fj.201801089R. Epub 2018 Aug 16.

PMID:
30113879
21.

An Engineered Distant Homolog of Pseudomonas syringae TTSS Effector From Physcomitrella patens Can Act as a Bacterial Virulence Factor.

Piechocki M, Giska F, Koczyk G, Grynberg M, Krzymowska M.

Front Microbiol. 2018 Jun 20;9:1060. doi: 10.3389/fmicb.2018.01060. eCollection 2018.

22.

Are age and anti-Müllerian hormone good predictors of ovarian reserve and response in women undergoing IVF?

Scheffer JAB, Scheffer B, Scheffer R, Florencio F, Grynberg M, Lozano DM.

JBRA Assist Reprod. 2018 Sep 1;22(3):215-220. doi: 10.5935/1518-0557.20180043.

23.

Fertility Preservation in Endocrine Disorders during Transition for Girls.

Bénard J, Sermondade N, Grynberg M.

Endocr Dev. 2018;33:128-148. doi: 10.1159/000487530. Epub 2018 Jun 8.

PMID:
29886500
24.

Medical techniques of fertility preservation in the male and female.

Vinolas C, Raad J, Sonigo C, Sifer C, Sermondade N, Grynberg M.

J Visc Surg. 2018 Jun;155 Suppl 1:S3-S9. doi: 10.1016/j.jviscsurg.2018.03.009. Epub 2018 May 19. Review.

PMID:
29784583
25.

Roughening of k-mer-growing interfaces in stationary regimes.

Grynberg MD, Schaposnik Massolo FI.

Phys Rev E. 2018 Feb;97(2-1):022125. doi: 10.1103/PhysRevE.97.022125.

PMID:
29548243
26.

A Proof-of-Concept Clinical Trial of A Single Luteal Use of Long-Acting Gonadotropin-Releasing Hormone Antagonist Degarelix in Controlled Ovarian Stimulation for In Vitro Fertilization: Long Antagonist Protocol.

Papanikolaou EG, Yarali H, Timotheou E, Grynberg M, Zafeiratis O, Tournaye H, Najdecki R.

Front Endocrinol (Lausanne). 2018 Mar 1;9:25. doi: 10.3389/fendo.2018.00025. eCollection 2018.

27.

The challenges of fertility preservation in cancer patients: an interview with Michael Grynberg.

Grynberg M.

Future Oncol. 2018 Mar;14(6):497-498. doi: 10.2217/fon-2017-0673. Epub 2018 Feb 9.

28.

[Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumors: Guidelines from the French national network dedicated to rare gynaecological cancer].

Rousset-Jablonski C, Selle F, Adda-Herzog E, Planchamp F, Selleret L, Pomel C, Chabbert-Buffet N, Daraï E, Pautier P, Trémollières F, Guyon F, Rouzier R, Laurence V, Chopin N, Faure-Conter C, Bentivegna E, Vacher-Lavenu MC, Lhomme C, Floquet A, Treilleux I, Lecuru F, Gouy S, Kalbacher E, Genestie C, de la Motte Rouge T, Ferron G, Devouassoux-Shisheboran M, Kurtz JE, Namer M, Joly F, Pujade-Lauraine E, Grynberg M, Querleu D, Morice P, Gompel A, Ray-Coquard I.

Bull Cancer. 2018 Mar;105(3):299-314. doi: 10.1016/j.bulcan.2017.10.032. French.

PMID:
29397916
29.

A model species for agricultural pest genomics: the genome of the Colorado potato beetle, Leptinotarsa decemlineata (Coleoptera: Chrysomelidae).

Schoville SD, Chen YH, Andersson MN, Benoit JB, Bhandari A, Bowsher JH, Brevik K, Cappelle K, Chen MM, Childers AK, Childers C, Christiaens O, Clements J, Didion EM, Elpidina EN, Engsontia P, Friedrich M, García-Robles I, Gibbs RA, Goswami C, Grapputo A, Gruden K, Grynberg M, Henrissat B, Jennings EC, Jones JW, Kalsi M, Khan SA, Kumar A, Li F, Lombard V, Ma X, Martynov A, Miller NJ, Mitchell RF, Munoz-Torres M, Muszewska A, Oppert B, Palli SR, Panfilio KA, Pauchet Y, Perkin LC, Petek M, Poelchau MF, Record É, Rinehart JP, Robertson HM, Rosendale AJ, Ruiz-Arroyo VM, Smagghe G, Szendrei Z, Thomas GWC, Torson AS, Vargas Jentzsch IM, Weirauch MT, Yates AD, Yocum GD, Yoon JS, Richards S.

Sci Rep. 2018 Jan 31;8(1):1931. doi: 10.1038/s41598-018-20154-1.

30.

Fertility Preservation in Women.

Grynberg M, Sonigo C, Santulli P.

N Engl J Med. 2018 Jan 25;378(4):400. doi: 10.1056/NEJMc1715731. No abstract available.

PMID:
29372989
31.

Fertility preservation in BRCA-mutated women: when and how?

Grynberg M, Raad J, Comtet M, Vinolas C, Cédrin-Durnerin I, Sonigo C.

Future Oncol. 2018 Feb;14(5):483-490. doi: 10.2217/fon-2017-0415. Epub 2018 Jan 12. Review.

PMID:
29327596
32.

Oocyte vitrification for preserving fertility in patients with endometriosis: first observational cohort study… and many unresolved questions. Letter to the Editor.

Raad J, Sonigo C, Tran C, Sifer C, Durnerin IC, Grynberg M.

Eur J Obstet Gynecol Reprod Biol. 2018 Jan;220:140-141. doi: 10.1016/j.ejogrb.2017.12.001. Epub 2017 Dec 5. No abstract available.

PMID:
29221758
33.

Antral follicle responsiveness to FSH, assessed by the follicular output rate (FORT), is altered in Hodgkin's lymphoma when compared with breast cancer candidates for fertility preservation.

Sonigo C, Comtet M, Duros S, Sifer C, Sermondade N, Grynberg M.

J Assist Reprod Genet. 2018 Jan;35(1):91-97. doi: 10.1007/s10815-017-1059-3. Epub 2017 Oct 6.

34.

Dysregulation of the Anti-Müllerian Hormone System by Steroids in Women With Polycystic Ovary Syndrome.

Pierre A, Taieb J, Giton F, Grynberg M, Touleimat S, El Hachem H, Fanchin R, Monniaux D, Cohen-Tannoudji J, di Clemente N, Racine C.

J Clin Endocrinol Metab. 2017 Nov 1;102(11):3970-3978. doi: 10.1210/jc.2017-00308.

PMID:
28938480
35.

Should we consider day-2 and day-3 embryo morphology before day-5 transfer when blastocysts reach a similar good quality?

Herbemont C, Sarandi S, Boujenah J, Cedrin-Durnerin I, Sermondade N, Vivot A, Poncelet C, Grynberg M, Sifer C.

Reprod Biomed Online. 2017 Nov;35(5):521-528. doi: 10.1016/j.rbmo.2017.07.014. Epub 2017 Aug 4.

PMID:
28887104
36.

Phase ordering dynamics of reconstituting particles.

Albarracín FAG, Rosales HD, Grynberg MD.

Phys Rev E. 2017 Jun;95(6-1):062130. doi: 10.1103/PhysRevE.95.062130. Epub 2017 Jun 22.

PMID:
28709284
37.

[Learning the gynecological examination on low-fidelity simulation: Impact on the feelings of medical students].

Hugon-Rodin J, Sonigo C, Drummond D, Grynberg M, Rodin T, Plu-Bureau G, Tesniere A.

Gynecol Obstet Fertil Senol. 2017 May;45(5):291-298. doi: 10.1016/j.gofs.2017.03.011. Epub 2017 Apr 29. French.

PMID:
28461236
38.

First mutation in the FSHR cytoplasmic tail identified in a non-pregnant woman with spontaneous ovarian hyperstimulation syndrome.

Hugon-Rodin J, Sonigo C, Gompel A, Dodé C, Grynberg M, Binart N, Beau I.

BMC Med Genet. 2017 Apr 26;18(1):44. doi: 10.1186/s12881-017-0407-6.

39.

Age as A Predictor of Embryo Quality Regardless of The Quantitative Ovarian Response.

Scheffer JB, Scheffer BB, de Carvalho RF, Rodrigues J, Grynberg M, Mendez Lozano DH.

Int J Fertil Steril. 2017 Apr-Jun;11(1):40-46. Epub 2016 Nov 11.

40.

Amino acid substitution equivalent to human chorea-acanthocytosis I2771R in yeast Vps13 protein affects its binding to phosphatidylinositol 3-phosphate.

Rzepnikowska W, Flis K, Kaminska J, Grynberg M, Urbanek A, Ayscough KR, Zoladek T.

Hum Mol Genet. 2017 Apr 15;26(8):1497-1510. doi: 10.1093/hmg/ddx054.

41.

[Does accumulation of oocytes benefit to women with poor ovarian reserve? No].

Gronier H, Sonigo C, Bringer S, Cedrin-Durnerin I, Hugues JN, Grynberg M.

Gynecol Obstet Fertil Senol. 2017 Mar;45(3):183-184. doi: 10.1016/j.gofs.2017.01.014. Epub 2017 Mar 1. French. No abstract available.

PMID:
28259705
42.

Reply to C.F. Hess et al.

Carde PP, Grynberg M, Poirot C, Glimelius B, Mounier N.

J Clin Oncol. 2017 Jan 20;35(3):374. doi: 10.1200/JCO.2016.69.7995. Epub 2016 Oct 28. No abstract available.

PMID:
28095265
43.

Letter in reply to "Fertility preservation before an ABVD protocol: no new evidence to support changing the recommendations".

Sonigo C, Sermondade N, Grynberg M.

Future Oncol. 2017 Mar;13(7):591-592. doi: 10.2217/fon-2016-0507. Epub 2016 Dec 8. No abstract available.

44.

The challenge of fertility preservation in cancer patients II: a themed issue of Future Oncology.

Grynberg M, Parker J, Dennis-Beron S.

Future Oncol. 2016 Oct;12(20):2291-2. doi: 10.2217/fon-2016-0387. No abstract available.

45.

Phosphatidylinositol-3-phosphate regulates response of cells to proteotoxic stress.

Kaminska J, Rzepnikowska W, Polak A, Flis K, Soczewka P, Bala K, Sienko M, Grynberg M, Kaliszewski P, Urbanek A, Ayscough K, Zoladek T.

Int J Biochem Cell Biol. 2016 Oct;79:494-504. doi: 10.1016/j.biocel.2016.08.007. Epub 2016 Aug 4.

46.

Should metaphase 1 and 2 stages oocytes be vitrified in the same time for fertility preservation?

Sifer C, Sellam-Chokron O, Sermondade N, Cedrin-Durnerin I, Sonigo C, Herbemont C, Grynberg M.

Future Oncol. 2016 Oct;12(20):2297-305. doi: 10.2217/fon-2016-0096. Epub 2016 Jul 12.

PMID:
27402453
47.

The challenge of fertility preservation in cancer patients: a special focus issue from Future Oncology.

Grynberg M.

Future Oncol. 2016 Jul;12(14):1667-9. doi: 10.2217/fon-2016-0250. No abstract available.

48.

Phosphorylation of spore coat proteins by a family of atypical protein kinases.

Nguyen KB, Sreelatha A, Durrant ES, Lopez-Garrido J, Muszewska A, Dudkiewicz M, Grynberg M, Yee S, Pogliano K, Tomchick DR, Pawłowski K, Dixon JE, Tagliabracci VS.

Proc Natl Acad Sci U S A. 2016 Jun 21;113(25):E3482-91. doi: 10.1073/pnas.1605917113. Epub 2016 May 16.

49.

Freezing oocytes or embryos after controlled ovarian hyperstimulation in cancer patients: the state of the art.

Bénard J, Duros S, El Hachem H, Sonigo C, Sifer C, Grynberg M.

Future Oncol. 2016 Jul;12(14):1731-41. doi: 10.2217/fon-2016-0095. Epub 2016 May 17. Review.

PMID:
27184037
50.

Metastable and scaling regimes of one-dimensional Kawasaki dynamics.

Albarracín FA, Rosales HD, Grynberg MD.

Phys Rev E. 2016 Apr;93:042120. doi: 10.1103/PhysRevE.93.042120. Epub 2016 Apr 18.

PMID:
27176267

Supplemental Content

Loading ...
Support Center